December 1st 2017
HOUSTON, Dec. 1, 2017 /PRNewswire/ -- Cellenkos Inc., an early stage clinical biotechnology company developing umbilical cord blood derived T-regulatory (Treg) cellular therapies for the treatment of autoimmune diseases and inflammatory disorders, announced today that Tara Sadeghi was appointed as Senior Director of Clinical Operations. Ms. Sadeghi joins Cellenkos, where she will provide senior oversight to clinical operations and ensure quality execution of all projects. “We are excited to have an experienced management team to which Tara Sadeghi brings over 25 years of clinical research experience, leadership and impeccable attention to detail. Her warmth of character and level of professionalism make her an outstanding fit with the Cellenkos family,” said Cellenkos Chief Medical Officer, Simrit Parmar, MD.